Methods are disclosed for reducing or ameliorating chronic rejection of a transplanted tissue by administration of an anti-IL-12 antibody, alone or in combination with other beneficial therapeutic agents.
Original languageEnglish (US)
Patent numberWO1999022766 A3
Priority date10/31/97
StatePublished - Aug 5 1999


Dive into the research topics of 'Use of anti-IL-12 antibodies in transplantation rejection'. Together they form a unique fingerprint.

Cite this